LQDA Liquidia Technologies Inc

P/E --
Forward P/E 14.08
Price/Sales 8.22
Beta 0.414
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Liquidia Technologies is trading 44% up in pre-market after United Therapeutics settlement resolves six lawsuits

Liquidia Technologies is trading 43.77% up at $38.54 in pre-market on October 14, after its October 13 agreement with United Therapeutics resolved all six...

🟢 Liquidia Technologies is trading 34.17% up in after-hours trading with no clear catalyst identified

Liquidia Technologies is trading at $35.97, up 34.17% after-hours; no clear catalyst has emerged. - The October 13 regular-session close was $26.81. - No...

🔴 Liquidia Technologies is trading 4.55% down today, with biotech weakness a possible factor

Liquidia Technologies is trading 4.55% down at $26.41, with biotech sector weakness a possible contributing factor. - No clear company-specific announcement...

🟢 Liquidia Technologies is trading 11.99% up; catalyst remains unclear

Liquidia Technologies is trading at $30.66, up 11.99%, with the cause of the gain unclear. - No clearly reported overnight catalyst was identified for October...

🟢 Liquidia Technologies is trading 4.3% up in pre-market with no clearly reported overnight catalyst

Liquidia Technologies is trading at $28.56, up 4.29%, in pre-market on October 12, with no clearly reported overnight catalyst identified. - Shares closed at...

🔴 Liquidia Technologies is trading 4.39% down today

Liquidia Technologies is trading 4.39% lower at $26.79, with no new company announcement identified to explain the October 9 decline. - The September 30...

🟢 Liquidia Technologies is trading 5.7% up today

Liquidia Technologies is trading at $28.20, up 5.70%, with no clear company-specific announcement identified to explain the gain. - The company’s...

🟢 Liquidia Technologies is trading 5% up today with no clear company-specific catalyst

Liquidia Technologies is trading 5.13% higher at $27.24 on October 7, 2026, with no clear driver identified. - No fresh company-specific announcement...

🔴 Liquidia Technologies is trading 4.4% down today as investors weigh Delaware patent ruling

Liquidia Technologies is trading 4.4% down at $24.77 as investors continue weighing the September 30 Delaware ruling on Yutrepia patents. - The ruling found...

🔴 Liquidia Technologies is trading 4.1% down today after Delaware ruling finds Yutrepia patent claims infringed

Liquidia Technologies is trading at $26.52, down 4.05%, as the September 30 Delaware ruling weighs. - The court found two United Therapeutics patent claims...

🔴 Liquidia Technologies is trading at 6.5% down today after ruling found Yutrepia infringes patent claims

Liquidia Technologies is trading 6.51% down at $26.77 after a September 30 Delaware ruling found Yutrepia infringes two valid United Therapeutics patent claims...

🔴 Liquidia Technologies is trading 5% down in pre-market after court finds Yutrepia infringes PH-ILD patents

Liquidia Technologies is trading 4.79% lower now at $26.65 after a Delaware federal court ruled that Yutrepia infringes two valid United Therapeutics patent...

Liquidia's Billion-Dollar Drug Just Hit a Legal Wall — Can the Company Survive Without Its Fastest-Growing Market?

Liquidia's Billion-Dollar Drug Just Hit a Legal Wall — Can the Company Survive Without Its Fastest-Growing Market?

Shares of Liquidia crashed as much as 57% on September 30 after a Delaware federal court ruled that its flagship lung drug infringes a valid United...

🔴 Liquidia Technologies is trading 22.7% down after court finds YUTREPIA infringed two patent claims

Liquidia Technologies is trading 22.7% down at $23.39 after a Delaware federal court found YUTREPIA infringed two valid United Therapeutics patent claims...

🔴 Liquidia Technologies is trading 11.1% down in pre-market after court finds YUTREPIA infringed two patent claims

Liquidia Technologies is trading 11.1% down now at $26.90 after a Delaware federal court found YUTREPIA infringed two valid claims of United Therapeutics’...

🔴 Liquidia Technologies is trading 4.63% down in pre-market after court finds YUTREPIA infringes two patent claims

Liquidia Technologies is trading 4.63% down at $28.86 in pre-market on October 1 after a Delaware federal judge found YUTREPIA infringes two valid claims of a...

Court Rules YUTREPIA® Infringes Two Claims of United Therapeutics Patent

Court Rules YUTREPIA® Infringes Two Claims of United Therapeutics Patent

Liquidia Corporation announced an adverse ruling in its Hatch-Waxman patent litigation with United Therapeutics. The U.S. District Court for the District of...

Liquidia Plunges Over 48% as Court Finds YUTREPIA Infringed United Therapeutics Patent

Liquidia Plunges Over 48% as Court Finds YUTREPIA Infringed United Therapeutics Patent

A U.S. District Court in Delaware ruled against Liquidia in its patent dispute with United Therapeutics. The court found that Liquidia’s drug, YUTREPIA,...

🔴 Liquidia Technologies is trading 22% down — catalyst remains unclear

Liquidia Technologies is trading at $55.30, down 21.77%, with no confirmed catalyst for the September 30, 2026 decline. - The latest identified company...

🔴 Liquidia Technologies is trading 5% down with no clear company-specific catalyst identified

Liquidia Technologies is trading at $67.14, down -5.01%; no clear company-specific announcement explaining the September 30 decline surfaced in the available...